Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Lilly gains after FDA approves weight-loss pill, sizing down investor doubts reut.rs/4c1P6Um https://reut.rs/4c1P6Um
2026-04-01T23:40:20.653Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.